Campylobacter seroconversion rates in selected countries in the European Union

Epidemiology and Infection

Volumn 141, Issue 10, 2013, Pages 2051-2057

  Teunis, P F M ^a,b   Falkenhorst, G ^c   Ang, C W ^d   Strid, M A ^c   De Valk, H ^e   Sadkowska Todys, M ^f   Zota, L ^g   Kuusi, M ^h   Rota, M C ⁱ   Simonsen, J B ^c   Molbak K ^c   Van Duynhoven, Y T H P ^a   Van Pelt, W ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EMORY UNIVERSITY   (United States)

^c STATENS SERUM INSTITUT   (Denmark)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f NATIONAL MEDICINES INSTITUTE   (Poland)

^g Centre for Communicable Diseases Prevention and Control   (Romania)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Campylobacter; epidemiology; incidence; serology; statistics

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BLOOD SAMPLING; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; CROSS-SECTIONAL STUDY; DENMARK; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN UNION; FEMALE; FINLAND; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; POLAND; POPULATION RESEARCH; ROMANIA; SEROCONVERSION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEROLOGIC TESTS;

EID: 84883332735     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002774     Document Type: Article

References (29)

1. Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: Playing chicken [Editorial commentary]. Clinical Infectious Diseases 2007; 44: 701-703
2. Kubota K, et al. Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus by using population-based telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006. Journal of Food Protection 2011; 74: 1592-1598
3. Havelaar AH, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. International Journal of Food Microbiology 2012a; 156: 231-238
4. EFSA. The community summary report on trends and sources of zoonoses and zoonotic agents in the European Union in 2007. EFSA Journal 2009; 223: 1-320
5. Endtz HP, et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. Journal of Clinical Microbiology 2000; 38: 2297-2301
6. Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: A true case of molecular mimicry. Trends in Immunology 2004; 25: 61-66
7. Tam CC, et al. Guillain-Barré syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2007; 2: E344
8. de Wit MAS, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: Incidence and etiology. American Journal of Epidemiology 2001; 154: 666-674
9. Amar CFL, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: Re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311-323
10. Madden RH, Moran L, Scates P. Frequency of occurrence of Campylobacter spp. in red meats and poultry in Northern Ireland and their subsequent subtyping using polymerase chain reaction-restriction fragment length polymorphism and the random amplified polymorphic DNA method. Journal of Applied Microbiology 1998; 84: 703-708
11. Altekruse SF, et al. Campylobacter jejuni-An emerging foodborne pathogen. Emerging Infectious Diseases 1999; 5: 28-35
12. Devane ML, et al. The occurrence of Campylobacter subtypes in environmental reservoirs and potential transmission routes. Journal of Applied Microbiology 2005; 98: 980-990
13. Nauta MJ, et al. Risk assessment of Campylobacter in the Netherlands via broiler meat and other routes. Technical Report 250 911 006, RIVM, Bilthoven, 2005 (http://www.rivm.nl/bibliotheek/rapporten/250911006. html
14. Teunis P, et al. A reconsideration of the Campylobacter dose-response relation. Epidemiology and Infection 2005; 133: 583-592
15. Strid MA, et al. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2 year follow-up study of 210 patients. Clinical and Diagnostic Laboratory Immunology 2001; 8: 314-319
16. Ang CW, et al. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clinical Microbiology and Infection 2007; 13: 915-922
17. Ang CW, et al. Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood. Epidemiology and Infection 2011; 139: 1361-1368
18. Falkenhorst G, et al. Serological cross-sectional studies on Salmonella incidence in eight European countries: No correlation with incidence of reported cases. BMC Public Health 2012; 12: 523-523
19. Versteegh FGA, et al. Age-specific long-Term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiology and Infection 2005; 133: 737-748
20. Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882-1895
21. Teunis PFM, et al. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479-489
22. Teunis PFM, et al. Biomarker dynamics: Estimating infection rates from serological data. Statistics in Medicine 2012; 31: 2240-2248
23. Doorduyn Y, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in the Netherlands: A case-control study. Epidemiology and Infection 2010; 138: 1391-1404
24. Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. Clinical Infectious Diseases 2007; 44: 718-725
25. Black RE, et al. Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988; 157: 472-479
26. Hellard ME, et al. Prevalence of enteric pathogens among community based asymptomatic individuals. Journal of Gastroenterology and Hepatology 2000; 15: 290-293
27. Ekdahl K, Giesecke J. Travellers returing to Sweden as sentinels for comparative disease incidence in other European countries, Campylobacter and Giardia as examples. Eurosurveillance 2004; 9: 1-9
28. Havelaar AH, et al. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiology and Infection. Published online :13 April 2012. doi:10.1017/S0950268812000568
29. Swart AN, et al. The protective effects of temporary immunity under imposed infection pressure. Epidemics 2012; 4: 43-47